KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer

PURPOSE: The KRAS gene frequently mutates in colorectal cancer (CRC). Here we investigated the prognostic and predictive role of KRAS mutation in patients with stage II or III CRC. EXPERIMENTAL DESIGN: A consecutive cohort of patients with stage II or III CRC from a single center database was studie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Deng, Yanhong, Wang, Li, Tan, Shuyun, Kim, George P., Dou, Ruoxu, Chen, Dianke, Cai, Yue, Fu, Xinhui, Wang, Lei, Zhu, Jun, Wang, Jianping
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528807/
https://ncbi.nlm.nih.gov/pubmed/25864038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.03.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados